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Causes of Hospital Mortality in Patients with Rheumatoid
Arthritis and Systemic Lupus Erythematosus in a University
Hospital: 1998–2015 Analysis
To the Editor: 
With great interest we read the article entitled “Hospitalizations in Patients
with Systemic Lupus Erythematosus in an Academic Health Science Center”
by Gu, et al1. They described the hospitalization of patients with systemic
lupus erythematosus (SLE) in an academic hospital over 2- and 3-year
periods. They found that incidental causes were most common (35.6%), and
that 21.4% and 22.4% of admissions were because of active SLE and
infection, respectively. We made a retrospective analysis of 1330 medical
records regarding hospitalization of SLE or rheumatoid arthritis (RA)
patients in an 18-year period. Table 1 shows the frequency of hospitalization
per year, and Table 2 shows the all-cause mortality trends. Of the 467 RA
hospital admissions, 5.1% of the patients died, and for the 863 SLE hospital
admissions, 22.1% died. In a subgroup analysis in 2008–2009, we found
that the mortality-associated factors corresponded to dyspnea as the chief
complaint symptom at admission (OR 5.8, 95% CI 1.6–14, p = 0.002) and
intensive care admission (OR 9.3, 95% CI 3–29, p = 0.04). Three or more
office/control consultations were associated with less mortality (OR 0.59,
95% CI 0.5–0.9, p = 0.03). Advances in the diagnosis and treatment of SLE
and RA have reduced the morbidity and mortality of both diseases.
Infectious and cardiovascular pathologies were the most frequent causes of
death. Considering these factors and the ones addressed by Gu K, et al is of
great importance in an academic/university field.
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Table 1. Hospital admissions and deaths per year. Data are n (%).
                Rheumatoid Arthritis Systemic Lupus Erythematosus
                                    Hospital Admissions,             Deaths,            Hospital Admissions,             Deaths, 
                                               n = 467                         n = 24                        n =  863                        n = 191
1998                                       6 (1.3)                           0 (0)                          19 (2.2)                        6 (31.6)
1999                                      12 (2.6)                         3 (25)                         38 (4.4)                        6 (15.8)
2000                                      22 (4.7)                          0 (0)                          21 (2.4)                         4 (19)
2001                                        14 (3)                            0 (0)                          36 (4.2)                        5 (13.9)
2002                                      17 (3.6)                          0 (0)                          22 (2.5)                         2 (9.1)
2003                                      26 (5.6)                          0 (0)                          65 (7.5)                       22 (33.8)
2004                                      33 (7.1)                        1 (3.03)                       40 (4.6)                        9 (22.5)
2005                                        28 (6)                         1 (3.57)                       64 (7.4)                        32 (50)
2006                                      27 (5.8)                          0 (0)                          39 (4.5)                        7 (17.9)
2007                                      34 (7.3)                          0 (0)                          33 (3.8)                        9 (27.3)
2008                                      40 (8.6)                          2 (5)                          49 (5.6)                       19 (38.8)
2009                                        28 (6)                            0 (0)                          53 (6.1)                        8 (15.1)
2010                                      24 (5.1)                       7 (29.17)                        60 (7)                        10 (16.7)
2011                                       27 (5.8)                          0 (0)                          51 (5.9)                        9 (17.6)
2012                                      31 (6.6)                        2 (6.45)                       80 (9.3)                        9 (11.3)
2013                                      41 (8.8)                       6 (14.63)                     88 (10.2)                       15 (17)
2014                                      40 (8.6)                          2 (5)                          66 (7.6)                       16 (24.2)
2015                                      17 (3.6)                          0 (0)                          39 (4.5)                         3 (7.7)
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Table 2. Mortality causes in rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Data are n (%).
Etiology                                                                                            RA, n = 24                           SLE, n = 191
Acute respiratory failure                                                                     7 (29.1)                                  46 (24)
Sepsis, unspecified                                                                               6 (25)                                  39 (20.4)
Other sudden death, cause unknown                                                  4 (16.6)                                 27 (14.1)
Alveolar and parietoalveolar conditions                                               0 (0)                                    12 (6.2)
Cardiac conduction disorder, unspecified                                             0 (0)                                     9 (4.7)
Systemic inflammatory response syndrome of infectious 
origin with organ failure                                                                   0 (0)                                     8 (4.1)
Cardiogenic shock                                                                               1 (4.1)                                    7 (3.6)
Acidosis                                                                                                 0 (0)                                       4 (2)
Pneumonia, unspecified                                                                        0 (0)                                       4 (2)
Hypovolemic shock                                                                              0 (0)                                       4 (2)
Bacterial meningitis, unspecified                                                          0 (0)                                     3 (1.5)
Disorder of central nervous system, unspecified                                  0 (0)                                     3 (1.5)
Endocarditis, valve unspecified                                                            0 (0)                                     3 (1.5)
Pneumonitis from food and vomit                                                        0 (0)                                     3 (1.5)
Chronic kidney disease                                                                         0 (0)                                     3 (1.5)
Histoplasmosis, unspecified                                                                  0 (0)                                       2 (1)
Other lipid storage disorders                                                                 0 (0)                                       2 (1)
Cardiac arrhythmia, unspecified                                                          1 (4.1)                                     2 (1)
Cerebrovascular diseases                                                                     2 (8.3)                                     2 (1)
Thoracoabdominal aortic aneurysm, without mention of rupture         0 (0)                                       2 (1)
Pulmonary edema                                                                                  0 (0)                                       2 (1)
Other diseases of jaws                                                                           0 (0)                                       2 (1)
Dilated cardiomyopathy                                                                       0 (0)                                     1 (0.5)
Hypertensive encephalopathy                                                               0 (0)                                     1 (0.5)
Interstitial pulmonary disease, unspecified                                         1 (4.1)                                     0 (0)
Cervical disc disorders                                                                        2 (8.3)                                     0 (0)
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